1Jennette JC,Falk R J,Andrassy K. Nomenclature of systemic vasculitides.Proposal of an international consensus conference[J].{H}ARTHRITIS AND RHEUMATISM,2004,(02):187-192.
2Sais G,Vidaller A,Jucgla A. Prognostic factors in leukocytoclastic vasculitis:a clinicopathologic study of 160 patients[J].{H}ARCHIVES OF DERMATOLOGY,2008,(03):309-315.
3Fiorentino DF. Cutaneous vasculitis[J].{H}Journal of The American Academy of Dermatology,2005,(03):311-340.
4Stone JH,Nousari HC. "Essential" cutaneous vasculitis:what every rheumatologist should know about vasculitis of the skin[J].{H}Current Opinion in Rheumatology,2001,(01):23-34.
5Carlson JA,Cavaliere LF,Grant-Kels JM. Cutaneous vasculitis:diagnosis and management[J].{H}CLINICS IN DERMATOLOGY,2008,(05):414-429.
6Sunderkotter C,Bonsmann G,Sindrilaru A. Management of leukocytoclastic vasculitis[J].{H}Journal of Dermatological Treatment,2007,(04):193-206.
7Sais G,Vidaller A,Jucgla A. Colchicine in the treatment of cutaneous leukocytoclastic vasculitis.Results of a prospective,randomized controlled trial[J].{H}ARCHIVES OF DERMATOLOGY,2005,(12):1399-1402.
8Chung L,Funke AA,Chakravarty EF. Successful use of rituximab for cutaneous vasculitis[J].{H}ARCHIVES OF DERMATOLOGY,2009,(11):1407-1410.
9Wisnieski JJ. Urticarial vasculitis[J].{H}Current Opinion in Rheumatology,2006,(01):24-31.
10Davis MD,Daoud MS,Kirby B. Clinicopathologic correlation of hypocomplementemic and nor-mocomplementemic urticarial vasculitis[J].{H}Journal of The American Academy of Dermatology,2002,(6/1):899-905.
